Back

Beta Bionics faces securities-fraud class action after 37% stock drop

Verifying
  • Bleichmar Fonti & Auld filed a securities-fraud class action against Beta Bionics and certain executives.
  • 37%: Beta Bionics shares fell $11.85 between January 8 and January 9, 2026.
  • Investors have until November 3, 2026, to seek lead-plaintiff appointment.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.